ROGER SHIFFMAN M.D. NPI 1033156682

NPI Information

  • NPI: 1033156682
  • Provider Name: ROGER SHIFFMAN, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5 HARRIS CT
    BLDG T, 2ND FLOOR SUITE 201
    MONTEREY, CA
    ZIP 93940
  • Phone: (831) 375-4105

Map and Directions

Get Directions

NPI Details

Roger Shiffman, M.D. is a hematology and oncology internal medicine in Monterey, CA. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Roger Shiffman, M.D. NPI is 1033156682. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5 HARRIS CT
BLDG T, 2ND FLOOR SUITE 201
MONTEREY, CA
ZIP 93940-750
Phone: (831) 375-4105
Fax: (831) 372-5722

The NPI 1033156682 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month (HCPCS:99491)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Vitamin d-3 level (HCPCS:82306)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)

The enumeration date for this NPI number is 6/1/2006 and was last updated on 1/15/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyC37008CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100C370080OTHERBCBS
2GR0080140OTHERCALIFORNIAMEDICAID GROUP
3A36443MEDICARE UPIN
400C370080MEDICARE PIN
5ZZZ13460ZOTHERMEDICARE GROUP #

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.